The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan
Crossref DOI link: https://doi.org/10.1007/s10147-017-1178-y
Published Online: 2017-08-09
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tsukada, Yoichiro http://orcid.org/0000-0002-2283-0078
Higashi, Takahiro
Shimada, Hideaki
Kikuchi, Yoshinori
Terahara, Atsuro
Funding for this research was provided by:
the National Cancer Center Research and Development Programs (28–A–21)
License valid from 2017-08-09